RALUCA TUDOREANU: Open Payments
NPI 1356849046 · WHITE HALL, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 24 payments from 10 companies in 2025. Trend: 2023 $280 · 2024 $63 · 2025 $535
Food & beverage: $460Education: $75
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $138 |
| Verona Pharma, Inc. | 4 | $84 |
| Viatris Specialty LLC | 4 | $71 |
| GENZYME CORPORATION | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Insmed, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ACTHAR, DUPIXENT, Ohtuvayre, YUPELRI, Arikayce, OPSUMIT, UPTRAVI, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
